Croma-Pharma GmbH, or Croma for short, is an international pharmaceutical company based in Leobendorf, Austria.

For over 40 years, Croma has been developing and producing innovative drugs and medical devices for the fields of ophthalmology, orthopedics and aesthetic dermatology. Croma is very proud to have made such an important contribution to improving health and quality of life for more than four decades. The company was founded in 1976 by a pharmacist Gerhard Prinz and is now currently managed by his sons Martin and Andreas Prinz. Since 2005, the company has been driven forward through rapid internationalisation. In 2014, the strategic sale of the Ophthalmology and Orthopedics divisions took place, since then the company has specialised in minimally invasive aesthetic medicine. Today Croma is a global player in the dynamically growing segment of minimally invasive aesthetic medicine and a leading European processor of hyaluronic acid. The company sells nearly six million hyaluronic acid syringes (injectables) annually through a network of in-house sales organisations, strategic partnerships and distributors in more than 70 countries. Production takes place exclusively at the company headquarters in Leobendorf near Vienna, Austria.

Besides a broad range of HA fillers from the own production site, Croma markets PDO lifting threads, a Platelet Rich Plasma (PRP) system and innovative skincare technologys in its core strategic markets.